These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2813453)

  • 1. Protection of 3'-azido-3'-deoxythymidine induced toxicity to murine hematopoietic progenitors (CFU-GM, BFU-E and CFU-MEG) with interleukin-1.
    Gallicchio VS; Doukas MA; Hulette BC; Hughes NK; Gass C
    Proc Soc Exp Biol Med; 1989 Nov; 192(2):201-4. PubMed ID: 2813453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
    J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Demonstration of a protector effect of interleukin-1 against hematologic toxicity of azidothymidine (AZT)].
    Arock M; Dedenon A; Damais C; Averlant G; Guillosson JJ
    C R Seances Soc Biol Fil; 1992; 186(3):206-14. PubMed ID: 1493577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of the hematopoietic toxicity associated with zidovudine in vivo with IL-1 alone or in combination with GM-CSF administered to normal mice.
    Gallicchio VS; Hughes NK; Tse KF; Gaines H
    Growth Factors; 1993; 9(3):177-83. PubMed ID: 8274295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS; Hughes NK; Tse KF
    Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic fibroblast growth factor (B-FGF) induces early- (CFU-s) and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFU-e) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro.
    Gallicchio VS; Hughes NK; Hulette BC; DellaPuca R; Noblitt L
    Int J Cell Cloning; 1991 May; 9(3):220-32. PubMed ID: 2061622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
    Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
    Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitro.
    Gallicchio VS; Hughes NK; Tse KF
    Int J Immunopharmacol; 1993 Feb; 15(2):263-8. PubMed ID: 8468123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of interleukin-3 on zidovudine (AZT)-induced in vitro toxicity to human hematopoietic progenitors.
    Gallicchio VS; Hughes NK
    Int J Cell Cloning; 1992 Mar; 10(2):99-104. PubMed ID: 1545155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
    Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
    J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S; Media JE; Nakeff A
    Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective modulation of the haematopoietic toxicity associated with zidovudine exposure to murine and human haematopoietic progenitor stem cells in vitro with lithium chloride.
    Gallicchio VS; Hughes NK
    J Intern Med; 1992 Mar; 231(3):219-26. PubMed ID: 1313488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of human granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein (PIXY321) on the hematopoietic toxicity associated with anti-viral drugs (zidovudine and didanosine) in vitro using normal human marrow cells.
    Gallicchio VS; Hughes NK
    Life Sci; 1995; 57(18):PL265-73. PubMed ID: 7475901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microenvironmental toxicity of azidothymidine: partial sparing with hemin.
    Abraham NG; Bucher D; Niranjan U; Brown AC; Lutton JD; Distenfeld A; Ahmed T; Levere RD
    Blood; 1989 Jul; 74(1):139-44. PubMed ID: 2752105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of heme for hemopoietic recovery from AZT toxicity.
    Loewy G; Cook P; Ahmed T; Lutton JD; Nishimura M; Distenfeld A; Levere RD; Abraham NG
    Hematol Pathol; 1992; 6(2):79-85. PubMed ID: 1607343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors.
    Grillon C; Bonnet D; Mary JY; Lenfant M; Najman A; Guigon M
    Stem Cells; 1993 Sep; 11(5):455-64. PubMed ID: 8241956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF.
    Castello G; Mela G; Cerruti A; Mencoboni M; Lerza R
    Exp Hematol; 1995 Dec; 23(13):1367-71. PubMed ID: 7498365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
    Harrison J; Kappas A; Levere RD; Lutton JD; Chertkov JL; Jiang S; Abraham NG
    Blood; 1993 Dec; 82(12):3574-9. PubMed ID: 8260696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of interleukin-3 (IL-3) on the hematopoietic toxicity associated with combination anti-viral drugs (zidovudine and DDI) in vitro using retrovirus-infected bone marrow cells.
    Gallicchio VS; Hughes NK
    Int J Immunopharmacol; 1994 Apr; 16(4):359-66. PubMed ID: 8045675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors.
    Hangoc G; Williams DE; Falkenburg JH; Broxmeyer HE
    J Immunol; 1989 Jun; 142(12):4329-34. PubMed ID: 2656864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.